Organ support & nutrition

Time to Continuous Renal Replacement Therapy Initiation and 90-Day Major Adverse Kidney Events in Children and Young Adults

JAMA Netw OpenPublished Retrospective cohort study

Main finding · MAKE-90Result — go to the resultOdds ratio 1.03 95% CI 1.02–1.04

Authors' conclusion

In this cohort study of children and young adults receiving CRRT, longer time to CRRT initiation was associated with greater risk of MAKE-90 outcomes, in particular, mortality.

Study context

Population
Children and young adults (birth to 25 years) receiving continuous renal replacement therapy (CRRT) for AKI or volume overload at 32 centers across 7 countries, WE-ROCK registry, 2015–2021after 27 exclusions
Participants
969 children
Exposure
Time to CRRT initiation from ICU admission
  • MAKE-90n = 630
Outcome
MAKE-90 (death, dialysis dependence, or persistent kidney dysfunction [>25% decline in eGFR from baseline])
Follow-up
90 days
Methodological detailsmultinational, multicentre registry, generalized propensity score-weighted, Statistical analysis February to July 2023
  • Multinational
  • Multicentre registry
  • Generalized propensity score-weighted
  • Statistical analysis February to July 2023

Main finding

MAKE-90

Odds ratio

1.03

95% CI 1.02–1.04

By group

Each 1-day delay in CRRT initiation
OR 1.03 (95% CI 1.02–1.04)

Each 1-day delay in CRRT initiation, as printed

As reported in the abstract

MAKE-90 occurred
630 (65.0%)
Died (of MAKE-90)
368 (58.4%)
Persistent kidney dysfunction among 601 survivors
262 (43.6%)
Dialysis dependent among those with persistent dysfunction
91 (34.7%)
Median (IQR) time to CRRT initiation, all
2 (1-6) days

Observational data: associations, not effects.

Original publication

Time to Continuous Renal Replacement Therapy Initiation and 90-Day Major Adverse Kidney Events in Children and Young Adults. JAMA Netw Open. Published 2 January 2024. doi:10.1001/jamanetworkopen.2023.49871

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.